You are here

Article metrics

Article menu
Immune cell therapies and immune cell engineering
Original research
Systemically administered low-affinity HER2 CAR T cells mediate antitumor efficacy without toxicity

 

Online download statistics by month:

Online download statistics by month: February 2024 to January 2026

AbstractFullPdf
Feb 2024830839317
Mar 2024580591309
Apr 2024487494203
May 2024294303160
Jun 2024324333163
Jul 2024338339144
Aug 2024262261156
Sep 2024285288478
Oct 2024356362132
Nov 2024295300155
Dec 2024330335143
Jan 2025364369171
Feb 2025409411154
Mar 2025258259200
Apr 2025297300191
May 2025290291129
Jun 202514715984
Jul 2025450
Sep 2025550
Jan 2026001
Total615562443290